Seven from VUMC among most highly cited researchersNov. 18, 2021, 9:33 AM
by Bill Snyder
Six current faculty members at Vanderbilt University Medical Center have made this year’s list of scientists whose papers have been cited most frequently by other researchers.
They are among 6,600 researchers around the world identified by the global analytics firm Clarivate whose publications rank in the top 1% by citations for field of research and publication year in the Web of Science citation index.
VUMC researchers on the list this year include:
- Mariana Byndloss, DVM, PhD, assistant professor of Pathology, Microbiology and Immunology, whose work has advanced understanding of how microorganisms in the intestines, the gut microbiome, may contribute to health and disease.
- James Crowe, Jr., MD, the Ann Scott Carell Professor, professor of Pediatrics and Pathology, Microbiology & Immunology, director of the Vanderbilt Vaccine Center, and a leader in the development of monoclonal antibodies to treat COVID-19.
- Mark Denison, MD, the Edward Claiborne Stahlman Chair in Pediatric Physiology and Cell Metabolism and an internationally known authority on coronavirus biology whose lab has aided development of antiviral drugs to treat COVID-19.
- Douglas Johnson, MD, MSCI, associate professor of Medicine, clinical director of Melanoma and co-leader of Translational Research and Interventional Oncology at the Vanderbilt-Ingram Cancer Center, and an expert in cancer immunotherapy.
- Dan Roden, MD, the Sam L. Clark, MD, PhD Chair, professor of Medicine, Pharmacology and Biomedical Informatics, Senior Vice President for Personalized Medicine, and a leader in pharmacogenomics and personalized medicine.
- C. Michael Stein, MBChB, the Dan May Professor and professor of Medicine and Pharmacology whose expertise in clinical pharmacogenomics has advanced understanding of why individuals differ in their responses to medications.
- Lynne Stevenson, MD, Lisa M. Jacobson Professor of Cardiovascular Medicine, and director of Cardiomyopathy, who has played a national role in the development of strategies and guidelines to decrease heart failure disease progression.
Roden and Stein have made the annual list during each of the past three years.
This year’s list includes 24 Nobel laureates, including five announced this year. Nearly 40% of the highly cited researchers are based in the United States, with China Mainland accounting for 14.2% and the United Kingdom 7.5%.
In a news release, Joel Haspel, Senior Vice President Strategy, Science at London-based Clarivate said, “This year’s data reflect a decade’s worth of research publications from the global scientific community.
“As well as documenting the ‘Eureka!’ moments, our data tell the story of late nights spent filling in grant applications, poring over results in the lab, the unsung work of peer reviewing contemporaries’ manuscripts, and the many small failures that ultimately lead to bigger successes and accelerating innovation,” Haspel said.